Neuvation Ventures


WHO ARE WE?



An independent for-profit fund responsible for identifying and investing in ideas, research, and early-stage companies within Neurodevelopmental Disorders (NDD), accelerating and transitioning them to successful commercialization. Our goal is to remove potential early-stage failures and increase offerings for the Neurodivergent community by creating a whole new market in this highly unmet need


See our team
Contact us

Not enough investments in technology and life sciences for Neurodevelopmental disorders (NDD)





Technology and Life Sciences are having a significant impact on healthcare and education, but not in neurological disorders such as autism (ASD) and intellectual disabilities. Over $268 B was spent on autism services in 2015, projected to be $450 B by 2024. Less than 1% of that spending has gone towards NDD tech or life sciences research and development. Focus on human services has crowded out investments in tech and life sciences, yet a single piece of technology can help more effectively in some cases than multiple aides. Neuvation Ventures plans to change this.


Research has made clear that high-quality early intervention can improve learning, communication, and social skills, as well as underlying brain development. However, existing early diagnostics and therapeutics are very limited or non-existent for some populations, with many children going either undiagnosed or improperly diagnosed until it is too late to intervene. Their struggles only expand as they age, as their life challenges may include below average or low IQ, underemployment, and non- or limited speech, anxiety, and depression



Need more focus on ideation





To achieve the goal of adding new companies and products, we need to focus more on translational research and early-stage companies in digital health, diagnostics, and therapeutics still in ideation. There need to be fundamental changes on how to approach the new solutions and that requires us to rethink how technology and life sciences are utilized for NDD.



Accelerating to success





We need to reduce the time it takes to get started, unblock funding hurdles, and offer a clear path to commercialization for products and ideas provided by these researchers and startups. We are partnering with Multiple Accelerator to provide a comprehensive curriculum and resources focused around NDD. By removing potential early-stage failures, we hope to increase offerings for the Neurodivergent community, while in turn, attracting more entrepreneurs and investors to produce better treatments and outcomes.



Goals





INCREASE INNOVATION



Identify talent within university research with promising products in the lab. Increase the total number of research projects in the labs that can be spun out as startups.



INCREASE EARLY-STAGE FUNDING



Provide pre-seed and seed funding to establish proof-of-concept (including efficacy research) and product-market fit.



INCREASE STARTUP SUCCESS



Created a curriculum, partnering with existing accelerator programs, tailored for NAID for startup success. We also assist startups to get early customers and provide mentoring as they grow.